1. Home
  2. IBRX vs FSS Comparison

IBRX vs FSS Comparison

Compare IBRX & FSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$7.94

Market Cap

6.1B

Sector

Health Care

ML Signal

N/A

Logo Federal Signal Corporation

FSS

Federal Signal Corporation

N/A

Current Price

$106.86

Market Cap

6.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
IBRX
FSS
Founded
2014
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.6B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
IBRX
FSS
Price
$7.94
$106.86
Analyst Decision
Strong Buy
Buy
Analyst Count
7
4
Target Price
$12.57
$131.75
AVG Volume (30 Days)
31.4M
425.6K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
0.52%
EPS Growth
38.71
14.57
EPS
N/A
4.01
Revenue
$113,288,000.00
$2,180,500,000.00
Revenue This Year
$88.57
$20.75
Revenue Next Year
$146.98
$7.37
P/E Ratio
N/A
$26.63
Revenue Growth
668.31
17.14
52 Week Low
$1.83
$66.47
52 Week High
$12.43
$132.89

Technical Indicators

Market Signals
Indicator
IBRX
FSS
Relative Strength Index (RSI) 49.64 37.75
Support Level $2.27 $106.69
Resistance Level $8.28 $115.55
Average True Range (ATR) 1.03 4.88
MACD -0.33 -1.22
Stochastic Oscillator 3.33 8.45

Price Performance

Historical Comparison
IBRX
FSS

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About FSS Federal Signal Corporation

Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates through two segments. The Environmental Solutions Group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group manufactures and supplies comprehensive systems and products used by law enforcement, fire rescue, and industrial sites to protect people and property. Its offerings include systems for community alerting and industrial communications. The company generates the majority of its revenue from the Environmental Solutions Group segment.

Share on Social Networks: